Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment

Widespread use of cephalosporin antibiotics in clinical practice calls for greater attention to the risk of adverse drug reactions. Information on serious or unexpected adverse events reported during post-marketing experience is submitted to national and international pharmacovigilance databases. An...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Yu. Demchenkova, G. I. Gorodetskaya, I. A. Mazerkina, M. V. Zhuravleva, A. S. Kazakov, M. V. Gorodetskiy, L. Yu. Badriddinova, S. Yu. Serebrova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2021-03-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/216
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849343330437038080
author E. Yu. Demchenkova
G. I. Gorodetskaya
I. A. Mazerkina
M. V. Zhuravleva
A. S. Kazakov
M. V. Gorodetskiy
L. Yu. Badriddinova
S. Yu. Serebrova
author_facet E. Yu. Demchenkova
G. I. Gorodetskaya
I. A. Mazerkina
M. V. Zhuravleva
A. S. Kazakov
M. V. Gorodetskiy
L. Yu. Badriddinova
S. Yu. Serebrova
author_sort E. Yu. Demchenkova
collection DOAJ
description Widespread use of cephalosporin antibiotics in clinical practice calls for greater attention to the risk of adverse drug reactions. Information on serious or unexpected adverse events reported during post-marketing experience is submitted to national and international pharmacovigilance databases. Analysis of these reports helps to identify new adverse drug reactions.The aim of the study was to analyse the safety profile of cephalosporin antibiotics based on spontaneous reports in the international VigiBase database.Materials and methods: the analysis of the adverse reaction profile of cephalosporin antibiotics was based on MedDRA system organ classes and included spontaneous reports submitted to VigiBase from the moment of its creation until August 2020.Results: the authors identified the most clinically significant adverse reactions for different cephalosporin generations. They compared and analysed information on adverse events in VigiBase and in patient information leaflets of medicinal products authorised in the Russian Federation. It was demonstrated that some serious events described in VigiBase spontaneous reports for V-generation cephalosporins are not included in the “Side effects” section of the patient information leaflets. According to VigiBase, the use of ceftaroline was associated with the development of generalised exfoliative dermatitis, Stevens–Johnson syndrome, tubulointerstitial nephritis, while the use of ceftolozane was associated with acute kidney injury, renal insufficiency, sepsis, pneumonia, and respiratory insufficiency.Conclusion: reporting of unexpected and serious adverse drug reactions to cephalosporin antibiotics is an important task of healthcare practitioners. Availability of information on class-specific and generation-specific serious adverse reactions will help predict and prevent their development.
format Article
id doaj-art-ab77cd53a2b8429695f47ccbb7203f7e
institution Kabale University
issn 2312-7821
2619-1164
language Russian
publishDate 2021-03-01
publisher Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Безопасность и риск фармакотерапии
spelling doaj-art-ab77cd53a2b8429695f47ccbb7203f7e2025-08-20T03:43:01ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642021-03-0191344210.30895/2312-7821-2021-9-1-34-42183Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic TreatmentE. Yu. Demchenkova0G. I. Gorodetskaya1I. A. Mazerkina2M. V. Zhuravleva3A. S. Kazakov4M. V. Gorodetskiy5L. Yu. Badriddinova6S. Yu. Serebrova7Scientific Centre for Expert Evaluation of Medicinal Products; I. M. Sechenov First Moscow State Medical UniversityScientific Centre for Expert Evaluation of Medicinal Products; I. M. Sechenov First Moscow State Medical UniversityScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal Products; I. M. Sechenov First Moscow State Medical UniversityScientific Centre for Expert Evaluation of Medicinal Products; Peoples’ Friendship University of RussiaPeoples’ Friendship University of RussiaI. M. Sechenov First Moscow State Medical UniversityScientific Centre for Expert Evaluation of Medicinal Products; I. M. Sechenov First Moscow State Medical UniversityWidespread use of cephalosporin antibiotics in clinical practice calls for greater attention to the risk of adverse drug reactions. Information on serious or unexpected adverse events reported during post-marketing experience is submitted to national and international pharmacovigilance databases. Analysis of these reports helps to identify new adverse drug reactions.The aim of the study was to analyse the safety profile of cephalosporin antibiotics based on spontaneous reports in the international VigiBase database.Materials and methods: the analysis of the adverse reaction profile of cephalosporin antibiotics was based on MedDRA system organ classes and included spontaneous reports submitted to VigiBase from the moment of its creation until August 2020.Results: the authors identified the most clinically significant adverse reactions for different cephalosporin generations. They compared and analysed information on adverse events in VigiBase and in patient information leaflets of medicinal products authorised in the Russian Federation. It was demonstrated that some serious events described in VigiBase spontaneous reports for V-generation cephalosporins are not included in the “Side effects” section of the patient information leaflets. According to VigiBase, the use of ceftaroline was associated with the development of generalised exfoliative dermatitis, Stevens–Johnson syndrome, tubulointerstitial nephritis, while the use of ceftolozane was associated with acute kidney injury, renal insufficiency, sepsis, pneumonia, and respiratory insufficiency.Conclusion: reporting of unexpected and serious adverse drug reactions to cephalosporin antibiotics is an important task of healthcare practitioners. Availability of information on class-specific and generation-specific serious adverse reactions will help predict and prevent their development.https://www.risksafety.ru/jour/article/view/216cephalosporinsadverse reactionsdrug safetydatabasespontaneous reportvigibasepharmacovigilance
spellingShingle E. Yu. Demchenkova
G. I. Gorodetskaya
I. A. Mazerkina
M. V. Zhuravleva
A. S. Kazakov
M. V. Gorodetskiy
L. Yu. Badriddinova
S. Yu. Serebrova
Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
Безопасность и риск фармакотерапии
cephalosporins
adverse reactions
drug safety
database
spontaneous report
vigibase
pharmacovigilance
title Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
title_full Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
title_fullStr Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
title_full_unstemmed Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
title_short Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
title_sort major aspects of detection and monitoring of adverse reactions associated with cephalosporin antibiotic treatment
topic cephalosporins
adverse reactions
drug safety
database
spontaneous report
vigibase
pharmacovigilance
url https://www.risksafety.ru/jour/article/view/216
work_keys_str_mv AT eyudemchenkova majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT gigorodetskaya majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT iamazerkina majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT mvzhuravleva majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT askazakov majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT mvgorodetskiy majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT lyubadriddinova majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment
AT syuserebrova majoraspectsofdetectionandmonitoringofadversereactionsassociatedwithcephalosporinantibiotictreatment